1 stock I’d consider now alongside Woodford Patient Capital Trust plc

Why I’m tempted to diversify my portfolio with these two tickers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Well-known fund manager Neil Woodford branched out from his successful income-first style of investing in 2015 with the launch of Woodford Patient Capital Trust (LSE: WPCT), which is listed in the FTSE 250 Index.

The trust takes a long-term approach to investing in mainly UK-based early-stage firms, which Neil Woodford believes will go on to deliver attractive returns to investors over time. As you’d expect, the trust focuses on the fundamentals of investee companies, but it also aims to support businesses through to commercialisation and fulfilment of their long-term potential. To me, as an individual investor, ‘supporting businesses’ is a bit of an alien concept that has hitherto found no place in my investing philosophy. My relatively small investments in individual firms don’t usually prop up a firm’s business model, and my aim is for the company to support me financially, not the other way round.

Attractive potential long-term rewards

Indeed, the Woodford website admits that investing in early-stage companies means “the risks are undoubtedly higher than in the more mainstream investment universe.”  Since the trust got going in the spring of 2015 the share price is down around 25%, suggesting that such risks have been biting. But the Woodford team is adamant that “when adjusted for these additional risks, the potential long-term rewards are extremely attractive.”

We don’t yet know if Woodford Patient Capital Trust will go on to perform well in the end, but we do know that by investing in it we can participate in a diversified range of early-stage businesses, which spreads the risk. One popular approach to investing in trusts and funds is to go for those that are underperforming based on the theory that they could be tomorrow’s winners and have their time in the sun. If Woodford is picking badly, he’ll be learning fast. If he’s unlucky, statistically he’ll likely be luckier down the road!

I think we can take diversification even further by mixing a trust like this with shares in individual firms. Woodford Patient Capital Trust invests in early-stage firms so why not hold shares in a more mature firm in your portfolio too, such as groundworks and engineering firm Keller Group (LSE: KLR)?

Trading well with a strong order book

Today’s full-year results from the firm show stellar progress. Revenue at constant currency rates came in 10% higher than a year ago and underlying earnings per share lifted 30%. The directors expressed their confidence in the outlook by pushing up the total dividend for the year by 20%.

Chief executive Alain Michaelis said in the report that the results were extremely strong” in the region of Europe, the Middle East and Africa (EMEA), and “solid” in North America, “but disappointing” in the Asia Pacific region. However, he thinks that ongoing operational improvements, strengthened leadership and a market recovery should return operations in the Asia Pacific region to profitability during 2018. The firm’s order book stands at an impressive £1bn or so, and most markets remain robust with bidding activity “at a healthy level.”

There’s bound to be a large element of cyclicality in the firm’s activities, but Keller is trading well and the outlook is robust. I think the tasty-looking quality and value metrics make the firm well worth your research time.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »